Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. (IONS) Revenue
Annual & quarterly revenue history · segment & region breakdown
IONS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsIonis Pharmaceuticals, Inc. trailing twelve-month (TTM) revenue is $1.06B, an increase of 33.87% year-over-year from $0.94B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.94B | +$0.24B | +33.87% |
| 2024-12-31 | $0.71B | -$0.08B | -10.48% |
| 2023-12-31 | $0.79B | +$0.20B | +34.10% |
| 2022-12-31 | $0.59B | -$0.22B | -27.53% |
| 2021-12-31 | $0.81B | +$0.08B | +11.13% |
| 2020-12-31 | $0.73B | -$0.39B | -35.04% |
| 2019-12-31 | $1.12B | +$0.52B | +87.20% |
| 2018-12-31 | $0.60B | +$0.09B | +16.63% |
| 2017-12-31 | $0.51B | +$0.14B | +37.93% |
| 2016-12-31 | $0.37B | +$0.09B | +31.40% |
Compare revenue vs peers
BiotechnologyCompare IONS revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Ionis Pharmaceuticals, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Ionis Pharmaceuticals, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Ionis Pharmaceuticals, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IONS revenue · 4 questionsIONS's trailing twelve-month (TTM) revenue is $1.06B. That is an increase of 33.87% year-over-year from $0.94B in FY2025.
▸ Source: FMP · Ionis Pharmaceuticals, Inc. SEC filings · GAAP · Ionis Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026